Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
4
×
deals
life sciences
national blog main
boston top stories
clinical trials
fda
national top stories
alnylam pharmaceuticals
boston
europe blog main
europe top stories
m&a
new york blog main
new york top stories
novartis
sanofi
abbvie
akouos
alexion pharmaceuticals
alirocumab
allergan
amag pharmaceuticals
amgen
amunix
amyotrophic lateral sclerosis (als)
anirvan ghosh
astrazeneca
autoimmune disorders
biogen
biopharma
bluerock therapeutics
boulder/denver blog main
boulder/denver top stories
cancer
cancer immunotherapy
cerovene
complement system
covid-19
What
deal
4
×
medicines
billion
drug
fda
acquire
acquisitions
agreed
alternative
announced
approval
autoimmune
betting
bio
biopharma
brings
candidate
cash
ceo
cholesterol
collabs
company
compound
covid
daniel
disease
duchenne
expensive
gene
gilead
gilead’s
help
historic
introduce
ipo
lead
medco
medicine
month
new
Language
unset
4
×
Current search:
deal
×
unset
×
" boston blog main "
×
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
Roche Puts Up Historic $1.15B for Sarepta Duchenne Gene Therapy Deal
@xconomy.com
4 years ago
Novartis to Acquire MedCo and FDA-Ready Cholesterol Drug for $9.7B
@xconomy.com
4 years ago
UCB Stakes Out Autoimmune Territory With $2.1B Deal for Ra Pharma